These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19751648)

  • 1. Successful treatment of repaglinide-induced hypoglycemia with octreotide.
    Fasano CJ; Rowden AK
    Am J Emerg Med; 2009 Jul; 27(6):756.e3-4. PubMed ID: 19751648
    [No Abstract]   [Full Text] [Related]  

  • 2. Octreotide therapy for nateglinide-induced hypoglycemia.
    Sherk DK; Bryant SM
    Ann Emerg Med; 2007 Dec; 50(6):745-6. PubMed ID: 18023765
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe hypoglycemia from clarithromycin-repaglinide drug interaction.
    Khamaisi M; Leitersdorf E
    Pharmacotherapy; 2008 May; 28(5):682-4. PubMed ID: 18447665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed hypoglycemia induced by repaglinide in a frail elderly adult with diabetes mellitus.
    Mennecart M; Mondon K; Malherbe C; Constans T
    J Am Geriatr Soc; 2014 Dec; 62(12):2460-2. PubMed ID: 25516054
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypoglycemia probably due to accidental intake of repaglinide.
    Lee IT; Sheu WH; Lin SY
    Chang Gung Med J; 2002 Nov; 25(11):783-6. PubMed ID: 12553369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of prandial glucose regulation with repaglinide in addressing the problem of hypoglycemia in the treatment of type 2 diabetes.
    Owens D
    J Assoc Physicians India; 2001 Jan; 49 Spec No():54-61. PubMed ID: 11235607
    [No Abstract]   [Full Text] [Related]  

  • 7. Symptomatic hypoglycemia associated with trimethoprim/sulfamethoxazole and repaglinide in a diabetic patient.
    Roustit M; Blondel E; Villier C; Fonrose X; Mallaret MP
    Ann Pharmacother; 2010 Apr; 44(4):764-7. PubMed ID: 20197475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe hypoglycaemia from repaglinide-brotizolam drug interaction: a case report and literature review.
    Khamaisi M
    Diabet Med; 2012 Sep; 29(9):1214-5. PubMed ID: 22414218
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric glipizide ingestion, onset of hypoglycemia, and octreotide.
    Osterhoudt KC; Calello DP
    J Pediatr Endocrinol Metab; 2009 Dec; 22(12):1185. PubMed ID: 20333881
    [No Abstract]   [Full Text] [Related]  

  • 10. Octreotide for paediatric sulfonylurea poisonings.
    Osterhoudt KC
    J Paediatr Child Health; 2009; 45(7-8):473. PubMed ID: 19712185
    [No Abstract]   [Full Text] [Related]  

  • 11. Repaglinide and diabetes: new preparation. No better than glucose-lowering sulphonamides.
    Prescrire Int; 2001 Feb; 10(51):9-11. PubMed ID: 11503861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
    Carr R; Zed PJ
    Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia.
    Graudins A; Linden CH; Ferm RP
    Am J Emerg Med; 1997 Jan; 15(1):95-6. PubMed ID: 9002583
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug-induced hypoglycaemia.
    Prescrire Int; 2009 Apr; 18(100):67. PubMed ID: 19585724
    [No Abstract]   [Full Text] [Related]  

  • 15. Risk of Hypoglycemia and Concomitant Use of Repaglinide and Clopidogrel: A Population-Based Nested Case-Control Study.
    Wei Y; Lin FJ; Lin SY; Wang CC
    Clin Pharmacol Ther; 2019 Dec; 106(6):1346-1352. PubMed ID: 31216051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure.
    Nzerue CM; Thomas J; Volcy J; Edeki T
    Int J Artif Organs; 2003 Jan; 26(1):86-9. PubMed ID: 12602474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea-induced hypoglycaemia: use of octreotide.
    Hanchard B; Boulouffe C; Vanpee D
    Acta Clin Belg; 2009; 64(1):56-8. PubMed ID: 19317242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octreotide for the treatment of sulphonylurea induced hypoglycaemia in type 2 diabetes.
    Braatvedt GD
    N Z Med J; 1997 May; 110(1044):189-90. PubMed ID: 9201206
    [No Abstract]   [Full Text] [Related]  

  • 19. Octreotide: a novel therapy for refractory sulfonylurea-induced hypoglycemia.
    Barkin JA; Block HM; Mendez PE
    Pancreas; 2013 May; 42(4):722-3. PubMed ID: 23591434
    [No Abstract]   [Full Text] [Related]  

  • 20. Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).
    Hussain K; Aynsley-Green A; Stanley CA
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():163-7. PubMed ID: 16456495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.